Topics

Companies Related to "Outcomes of Surgical Resection After Induction Treatment in Non-Small Cell Lung Cancer (SRaIT)" [Most Relevant Company Matches] RSS

22:08 EST 18th January 2020 | BioPortfolio

Here are the most relevant search results for "Outcomes of Surgical Resection After Induction Treatment in Non-Small Cell Lung Cancer (SRaIT)" found in our extensive corporate database of over 50,000 company records.

Showing "Outcomes Surgical Resection After Induction Treatment Small Cell" Companies 1–25 of 6,900+

Relevant

NiTi Surgical Solutions

NiTi Surgical Solutions is focused on the BioDynamix of natural healing, offering state-of-the-art medical devices designed to optimize surgical outcomes for patients and physicians. NiTi Surgical Solutions currently markets its novel ColonRing device - the next generation of closure technology for colorectal resection - providing surgeons with a potential...


Puracyp, Inc.

Puracyp began operations in 1993 focusing on the distribution of monospecific inhibitory antibodies to several human P450 enzymes. Members of the pharmaceutical industry used these antibodies to assess the contribution of a single P450 enzyme to a drug metabolizing reaction. Researchers also used anti-human P450 immunoglobulins in Western blotting experiments to determine expression of individual ...

NiTi Medical Technologies Ltd.

NiTi Medical Technologies provides groundbreaking surgical devices for gastrointestinal diseases such as cancer and obesity for which intestinal resection and anastomosis are indicated.The broad line of devices and the techniques they employ have the potential to advance surgical compression anastomosis procedures and to improve procedural efficiency and patient recovery.NiTi's patented nickel tit...


CARLSMED, Inc.

CARLSMED is leveraging AI and predictive analytics to utilize prior outcomes data for personalizing the treatment of complex adult spinal deformities. The company’s proprietary PACC platform makes surgical plans and devices tailored to the precise medical situation of every individual patient. This is transforming healthcare by finally giving spine surgeons the tools to obtain better results...

Incara Pharmaceuticals

Incara Pharmaceuticals Corporation focuses on the protection and regeneration of tissue damaged by injury and disease. The company currently has programs in three areas: liver cell therapy and progenitor cell therapy as a treatment for liver failure; small molecule catalytic antioxidants as treatment for stroke and tissue damage; and deligioparin (formerly named OP2000), an ultra-low molecular wei...

ZipLine Medical, Inc.

ZipLine Medical (www.ziplinemedical.com), headquartered in Campbell, Calif., is an emerging medical device company developing cost-effective, non-invasive surgical skin closure devices for suture-like outcomes at the speed of staples, with a reduced risk of surgical site infection. Because skin-closure is the common denominator of nearly all surgical proce...

Cell Medica Limited

Cell Medica is a cellular therapeutics company engaged in the development, manufacturing and marketing of T cell immunotherapy approaches for the treatment of infections and cancers related to oncogenic viruses. The Company’s lead cell product, CytovirTM CMV, for the treatment and prevention of cytomegalovirus (CMV) infections in patients following al...

TriSalus™ Life Sciences

TriSalus Life Sciences is committed to transforming outcomes for patients with pancreatic cancer and other solid tumors. Our solution is bold: to integrate novel and proprietary therapeutics with the TriSalus Pressure-Enabled Drug Delivery™ (PEDD™) technology. It’s a comprehensive approach intended to improve treatment response and, ultimately, ...

ARC Pharmaceuticals Inc

ARC Pharmaceuticals Inc. is a privately owned biotechnology company developing innovative medical products for the treatment of proliferative diseases. The Company holds exclusive intellectual property related to the treatment of surgical adhesions, rheumatoid arthritis, osteoarthritis and psoriasis. ARC's initial focus is on the prevention of surgical adhesion disease, a major complication in a...

Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its proprietary cell-based therapy platform and associated development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally-differentiated human cells from its pluripotent and proge...

Opexa Therapeutics

Opexa Therapeutics is a commercialization driven biotechnology cellular therapy company that develops autologous personalized cell therapies for the treatment of various diseases. The Company is focused on its proprietary stem cell and T-cell technologies for the autologous use of peripheral blood derived adult stem cells in regenerative medicine as well as T cells for the treatment of autoimmune ...

Vion Pharmaceuticals

Vion Pharmaceuticals, Inc. is developing novel agents for the treatment of cancer. We have two small molecule anticancer compounds under evaluation in human clinical trials. Our product, Cloretazine® (VNP40101M) is currently being studied for the treatment of acute myelogenous leukemia (AML), including a pivotal Phase 2 trial in elderly de novo poor-risk AML. In addition a trial of Cloretazine® ...

Alfacell Corporation

Alfacell Corporation is a biopharmaceutical company primarily engaged in the discovery and development of a new class of anti-cancer drugs from amphibian ribonucleases ("RNases"). RNases degrade ribonucleic acids ("RNA") causing an interruption in protein synthesis resulting in inhibition of cell growth and induction of apoptosis (programmed cell death). The Company's first produ...

Telik, Inc.

Telik, Inc. of Palo Alto, CA, is a clinical stage drug development company focused on discovering and developing small molecule drugs to treat cancer. The company's most advanced drug candidates in clinical development are Telintra, a modified glutathione analog for the treatment of MDS and Severe Chronic Neutropenia (SCN), and Telcyta®, a cancer activated prodrug for the treatment of advanced n...

Health Outcomes Sciences

Health Outcomes Sciences is propelling the practice of precision medicine through its patented content enablement platform, ePRISM®, which translates scientific models into automated evidence-based decision support solutions. By helping health and life science organizations -- as well as allied technology partners -- deliver the power of personalized pr...

Beta-Cell

Beta-Cell is engaged in the development and commercialisation of innovative cell and drug therapies for the treatment of diabetes. The primary therapeutic focus of the company is on beta-cells, the highly specialized endocrine cells located in pancreatic islets and responsible for producing insulin. Beta-Cell has an advanced pre-clinical xeno-transplantation program based on its proprietary techno...

SBH Sciences

SBH Sciences is a well-established, profitable, and expanding small Biotechnology company. We specialize in cell culture, using mammalian and insect cell lines and in the development of cell-based bioassays. Our proprietary processes have achieved commercial production of highly purified monoclonal antibodies and recombinant cytokines.

Intec Pharma Ltd.

Intec Pharma Ltd. is a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and s...

Breast Treatment Associates

Located in Fayetteville, Breast Treatment Associates is headed by Michael J. Cross, M.D., F.A.C.S., a Surgical Oncologist who specializes in the diagnosis and treatment of medical and surgical diseases of the breast. He is board-certified by the American Board of Surgery. Dr. Cross is a fellow of the American College of Surgeons and a member of the America...

Protox Therapeutics Inc.

Protox Therapeutics is a product-focused development-stage company and a leader in advancing novel, targeted protein toxin therapeutics for the treatment of cancer and other proliferative diseases. Through the company’s INxin™ and PORxin™ technology platforms, therapeutic candidates are generated by engineering the naturally occurring toxins, Pseudomonas exotoxin and proaerolysin. These drug...

Bariatric Partners, Inc.

Headquartered in Charlotte, North Carolina, Bariatric Partners, Inc. is a national for-profit healthcare company that specializes in partnering with leading bariatric surgeons across the country to provide minimally invasive surgical treatment for the disease of obesity. Bariatric Partners, Inc., along with its physician partners, owns and operates specialty ambulatory surgical centers - branded u...

First Surgical Partners Inc.

First Surgical Partners Inc. (“First Surgical”) operates two ambulatory surgery centers and a general acute care hospital in the Houston area. The surgeons that utilize First Surgical’s facilities perform non life-threatening surgeries at these locations. The procedures performed include bariatric, reconstructive and cosmetic plastics, orthopedics,...

Innovia Medical

Innovia Medical is a family of specialty surgical companies that are passionately committed to partnering with medical professionals to help elevate the delivery of patient care and improve clinical outcomes.

ImmunoGen

ImmunoGen, Inc. develops pharmaceuticals, primarily for the treatment of cancer. The Company's product candidates arecalled tumor-activated prodrugs ("TAPs") and are based on its proprietary immunoconjugate technology platform. Unlike conventional chemotherapeutic agents, TAPs are intended to deliver potent chemotherapy specifically to a tumor. Each TAP immunoconjugate comprises a small-molecule d...

RF Surgical Systems Inc.

RF Surgical Systems, Inc. is the market leader in the detection and prevention of retained surgical items. The RF Surgical Detection System is the preferred solution in more than 300 U.S. hospitals and surgical centers. A number of US News & World Report "Honor Roll" hospital recipients recently joined the fast-growing list of care providers benefiting fro...


More From BioPortfolio on "Outcomes of Surgical Resection After Induction Treatment in Non-Small Cell Lung Cancer (SRaIT)"

Quick Search

Corporate Database Quicklinks